Breaking
🇺🇸 FDA
Miracell's SMART M-CELL Stem Cell Therapy Shows Cognitive Improvement in Severe Alzheimer's Patients
NewsAlzheimer's Disease/Neurodegenerative DisordersApr 25, 2026

Miracell's SMART M-CELL Stem Cell Therapy Shows Cognitive Improvement in Severe Alzheimer's Patients

Miracell reports positive Phase 2 results for SMART M-CELL CD34+ stem cell therapy showing cognitive improvement in moderate to severe Alzheimer's patients.

Dr. Natalie Hughes
Oryon Cell Therapies Appoints Dr. Burkhard Blank as Chief Medical Officer to Lead Clinical Development
NewsApr 15, 2026

Oryon Cell Therapies Appoints Dr. Burkhard Blank as Chief Medical Officer to Lead Clinical Development

Oryon Cell Therapies names Dr. Burkhard Blank as CMO to advance clinical-stage cell therapy programs and strengthen leadership team in biotechnology sector.

Dr. Sarah Mitchell